iTeos Therapeutics has said it is evaluating with partner GlaxoSmithKline whether to conduct additional clinical trials of TIGIT drug EOS-448 following the failure of a key trial for Roche's rival ...
GSK and iTeos anti-TIGIT antibody belrestotug showed efficacy in a phase 2 trial in PD-L1-positive non-small cell lung cancer (NSCLC), providing some much-needed positive news for the beleaguered ...
No other corporate actions details are available. Scooters India share price was Rs 78.80 as on 11 Jun, 2024, 03:56 PM IST. Scooters India share price was up by 9.99% based on previous share price of ...
Mopeds and scooters are similar vehicles, but there are distinct differences between them in terms of top speed, engine size, and chassis design. As a result, insurance requirements for each differ, ...
The data, shared at this week’s Society for Immunotherapy of Cancer annual meeting, could help reignite interest in TIGIT inhibition, after several setbacks in the field. The ARC-10 study evaluated ...
Arcus Biosciences unveiled data from a terminated late-stage study of its TIGIT and PD-1 drug combo that it says supports its decision to take the … ...
This is the quintessential scooty. The scooter that gave the name to the segment. The TVS Scooty Pep is the smallest displacement automatic scooter sold in the Indian market today. The scooter ...
The scooter is lightweight at 104kg and offers a fuel economy of 48km/l. The TVS Ntorq comes powered by a 124cc, single-cylinder engine that produces 10.05bhp of power and 10.8Nm of torque.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback